Glialign

0 followers


Glialign is developing a novel cell therapy for peripheral nerve repair — for which current therapies are only successful in less than half of the cases and often can require grafting of a nerve from another part of the body.

Employees

1-10

Links

Org chart

John Sinden

Collapse
James Phillips
Chief Scientific Officer

Teams

This company has no teams yet